Jiawei Liang

Jan 5, 2024 | aging-us.com | Jiahong Cai |Yong’an Jiang |Peng R. Chen |Jiawei Liang

Background: Glioma is one of the most aggressive malignant brain tumors and is characterized by invasive growth and poor prognosis. TBC1D1, a member of the TBC family, is associated with the development of various malignancies. However, the role of TBC1D1 in glioma-genesis remains unclear. Methods: The effect of TBC1D1 on the prognosis of glioma patients and related influencing factors were analyzed in the Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) databases.

Jan 5, 2024 | aging-us.com | Jiahong Cai |Yong’an Jiang |Peng R. Chen |Jiawei Liang

Research Paper Volume 16, Issue 1 pp 431—444 1 Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China 2 Department of Neurology, Shang Rao GuangXin District People’s Hospital, Shangrao 334100, Jiangxi, China 3 Department of Neurosurgery, Nanchang County People’s Hospital, Nanchang 330200, Jiangxi, China https://doi.org/10.18632/aging.205377 How to Cite Cite this Article Select the format you require from the list below Click to copy...

Nov 15, 2023 | onlinelibrary.wiley.com | Yin Zhang |Ranran Yu |Cheng Zhao |Jiawei Liang

1 Introduction Pancreatic cancer is a devastating malignancy characterized by a high fatality rate,[1] primarily attributed to the formidable challenges in early diagnosis.[2] BRD4, a member of the Bromodomain and Extraterminal (BET) protein family, is a promising target for anticancer drugs due to its involvement in organizing super-enhancers (SEs) and regulating the expression of oncogenes.[3] Inhibiting BRD4 disrupts the communication between SEs and target promoters, leading to the...

May 31, 2023 | onlinelibrary.wiley.com | Yong’an Jiang |Peng Yun Chen |Jiawei Liang |Jiahong Cai

1 INTRODUCTION Meningiomas are primary intracranial tumors, with majority of them being benign. Non-malignant meningiomas (NMMs) are the most common histological type, accounting for more than half of the primary brain and central nervous systems.1 Following the enactment of the Benign Brain Tumor Cancer Registries Amendment Act, there has been increased research on NMMs.2 NMMs cause a series of damage by compressing brain tissues in various anatomical regions, which vary patient-to-patient.